New PACS software extends integrated functionality and minimizes need to use third party tools

New PACS software extends integrated functionality and minimizes need to use third party tools.

Version 4.7 of leading image archiving and transmission platform offers enhanced radiological and clinical tools.

 

Louvain-la-Neuve, (Belgium), 9. November, 2015 –Telemis, the medical imaging, archiving and transmission specialist, has launched a new version of its popular PACS (Picture Archiving and Communication System) software at the Journées Françaises de Radiologie (JFR) technical exhibition and congress in Paris. Telemis-Medical PACS version 4.7 offers new tools for radiologists that include a 4-dimensional magnetic resonance examination viewer, integrated "tumor follow-up" capabilities, and a more efficient volume measurement tracking system. The work of clinicians is further simplified through the availability of 3D visualization and the ability to transfer 360° medical imaging.

High levels of built-in functionality mean that Telemis-Medical PACS version 4.7 improves efficiency by reducing the need to switch to third-party imaging solutions. For example, based on research and validation from its customers – including academics, hospitals and practices – Telemis now offers default and advanced multi-echo magnetic resonance and multi-phase visualization tools. For oncology pathologies, which represent more than 40% of cases where PACS software is used, flexible and user-friendly integrated tumor tracking simplifies the management of histories stored on CD-ROM and the monitoring of progress against CHOI, PERCIST and RECIST criteria (1). Clinicians will also benefit from a new three-dimensional visualization tool that better represents pathologies and makes explanations to patients easier.

In addition to visualization, version 4.7 also focuses on improved communication. The integration of the "Skype in 1 click" module, for example, improves the dialogue between physicians and, in the case of teleradiology, with imaging technologists.

Telemis Group CEO, Stephane Ketelaer, says: "Communication between specialists is fundamental, as is communication between our users and our engineers. Customer satisfaction, built on strong relationships and excellent customer service is at the heart of what we do. This is why, in addition to our hotline service and our base of field engineers, we have integrated a feature into 4.7 that allows any user to connect with a single click to our support platform; whether to request information, participate in discussions on forums, or to signal the need for intervention."

As in previous years, Telemis used the JFR event to present its latest prototypes and cutting-edge technologies. Visitors were able to share their views with Telemis engineers, discuss the benefits of the various concepts presented during the show, and vote for their favorite technology prototypes. Concepts that received most votes are likely to be incorporated into future versions of Telemis-Medical PACS.

 

(1) RECIST, PERCIST and CHOI criteria are three tumors evaluation medical criteria commonly used in the oncological aftercare.

November 9, 2015